Generation of composite dose and biological effective dose (BED) over multiple treatment modalities and multistage planning using deformable image registration

Medical Dosimetry

Volumn 35, Issue 2, 2010, Pages 143-150

  Zhang, Geoffrey ^a   Huang, Tzung Chi ^a   Feygelman, Vladimir ^a   Stevens, Craig ^a   Forster, Kenneth ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

BED; Composite plans; Deformable image registration

Indexed keywords

IODINE 125;

ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; HUMAN; IMAGE RECONSTRUCTION; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RADIATION INJURY REPAIR; TREATMENT PLANNING; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 77952504573     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meddos.2009.05.001     Document Type: Article

References (33)

1. Mock U., Kucera H., Fellner C., et al. High-dose-rate (HDR) brachytherapy with or without external beam radiotherapy in the treatment of primary vaginal carcinoma: Long-term results and side effects. Int. J. Radiat. Oncol. Biol. Phys. 2003, 56:950-957.
2. Wang J.Z., Li X.A. Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose. Med. Phys. 2003, 30:34-40.
3. Blasko J., Ragde H., Cavanagh W., et al. Long term outcomes of external beam irradiation and I-125/Pd-103 brachytherapy boost for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1996, 36:198.
4. Li J.G., Williams S.S., Goffinet D.R., et al. Breast-conserving radiation therapy using combined electron and intensity-modulated radiotherapy technique. Radiother. Oncol. 2000, 56:65-71.
5. Ling C.C., Burman C., Chui C.S., et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int. J. Radiat. Oncol. Biol. Phys. 1996, 35:721-730.
6. Hansen E.K., Bucci M.K., Quivey J.M., et al. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2006, 64:355-362.
7. Barker J.L., Garden A.S., Ang K.K., et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int. J. Radiat. Oncol. Biol. Phys. 2004, 59:960-970.
8. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat. Res. 1985, 104:S13-S19.
9. Oetzel D., Schraube P., Hensley F., et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int. J. Radiat. Oncol. Biol. Phys. 1995, 33:455-460.
10. Guerrero T., Zhang G., Huang T.-C., et al. Intrathoracic tumour motion estimation from CT imaging using the 3D optical flow method. Phys. Med. Biol. 2004, 49:4147-4161.
11. Gao S., Zhang L., Wang H., et al. A deformable image registration method to handle distended rectums in prostate cancer radiotherapy. Med. Phys. 2006, 33:3304-3312.
12. Zhang G., Huang T.-C., Forster K., et al. Dose mapping: Validation in 4D dosimetry with measurements and application in radiotherapy follow-up evaluation. Comp. Meth. Prog. Biomed. 2008, 90:25-37.
13. Flampouri S., Jiang S.B., Sharp G.C., et al. Estimation of the delivered patient dose in lung IMRT treatment based on deformable registration of 4D-CT data and Monte Carlo simulations. Phys. Med. Biol. 2006, 51:2763-2779.
14. Bookstein F.L. Principal warps: Thin-plate splines and the decomposition of deformations. IEEE. Trans. Pattern. Anal. Mach. Intell 1989, 11:567-585.
15. Dale R.G. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br. J. Radiol 1985, 58:515-528.
16. Jani A.B., Hand C.M., Lujan A.E., et al. Biological effective dose for comparison and combination of external beam and low-dose rate interstitial brachytherapy prostate cancer treatment plans. Med. Dosim. 2004, 29:42-48.
17. Ling C. Permanent implants using Au-198, Pd-103 and I-125: Radiobiological considerations based on the linear quadratic model. Int. J. Radiat. Oncol. Biol. Phys. 1992, 23:81-87.
18. Wahba G. Spline Models for Observational Data 1990, Society for Industrial and Applied Mathematics, Philadelphia.
19. Horn B.K.P., Schunck B.G. Determining optical flow. Artif. Intell. 1981, 17:185-203.
20. Jones B., Dale R.G. Mathematical models of tumour and normal tissue response. Acta. Oncol. 1999, 38:883-893.
21. Arai T., Kuroishi T., Saito Y., et al. Tumor doubling time and prognosis in lung cancer patients: Evaluation from chest films and clinical follow-up study. Jpn. J. Clin. Oncol. 1994, 24:199-204.
22. Dale R.G. Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model. Br. J. Radiol 1989, 62:241-244.
23. Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1999, 43:1095-1101.
24. Carlson D., Stewart R., Li X., et al. Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer. Phys. Med. Biol. 2004, 49:4477-4491.
25. Fowler J., Chappell R., Ritter M. Is α/β for prostate tumors really low?. Int. J. Radiat. Oncol. Biol. Phys. 2001, 50:1021-1031.
26. Wang J.Z., Guerrero M., Li X.A. How low is the α/β ratio for prostate cancer?. Int. J. Radiat. Oncol. Biol. Phys. 2003, 55:194-203.
27. Brenner D.J. Toward optimal external-beam fractionation for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2000, 48:315-316.
28. Brenner D.J. Hypofractionation for prostate cancer radiotherapy-What are the issues?. Int. J. Radiat. Oncol. Biol. Phys. 2003, 57:912-914.
29. Kampinga H., Hiemstra Y., Konings A., et al. Correlation between slowly repairable double-strand breaks and thermal radiosensitization in the human HeLa S3 cell line. Int. J. Radiat. Biol. 1997, 72:293-301.
30. Brenner D., Armour E., Corry P., et al. Sublethal damage repair times for a late-responding tissue relevant to brachytherapy (and external-beam radiotherapy): Implications for new brachytherapy protocols. Int. J. Radiat. Oncol. Biol. Phys. 1998, 41:135-138.
31. Peschel R.E., Chen Z., Roberts K., et al. Long-term complications with prostate implants: Iodine-125 vs. Palladium-103. Radiat. Oncol. Invest. 1999, 7:278-288.
32. Digital Imaging and Communications in Medicine (DICOM) 2001, NEMA, National Electrical Manufacturers Association, Rosslyn, VA.
33. Mehta M., Scrimger R., Mackie R., et al. A new approach to dose escalation in non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2001, 49:23-33.